1. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking, and myocardial infarction. N Engl J Med 1981;304:465-468.
2. Grimm RH, Jr Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985;254:1932-1937.
3. Eryd SA, Smith JG, Melander O, et al. Incidence of Coronary Events and Case Fatality Rate in Relation to Blood Lymphocyte and Neutrophil Counts. Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32:533-539.
4. Furman MI, Becker RC, Yarzebski J, et al. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 1996;78:945-948.
5. Sevuk U, Bilgic A, Altindag R, et al. Value of the neutrophil-to-lymphocyte ratio in predicting post-pericardiotomy syndrome after cardiac surgery. Eur Rev Med Pharmacol Sci 2016;20:906-911.
6. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007;154:995-1002.
7. Azab B, Shariff MA, Bachir R, et al. Elevated preoperative neutrophil/lymphocyte ratio as a predictor of increased long-term survival in minimal invasive coronary artery bypass surgery compared to sternotomy. J Cardiothorac Surg 2013;8:193.
8. Blum A, Vardinon N, Kaplan G, et al. Autoimmune and inflammatory responses may have an additive effect in postpercutaneous transluminal coronary angioplasty restenosis. Am J Cardiol 1998;81:339-341.
9. Blum A, Sclarovsky S, Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995;91:20-22.
10. Mukamal KJ, Wellenius GA, Mittleman MA. Hematologic parameters, atherosclerotic progression, and prognosis in patients with previous coronary artery bypass grafting (from the Post CABG Trial). Am J Cardiol 2009;103:328-332.
11. Hawkes AL, Nowak M, Bidstrup B, et al. Outcomes of coronary artery bypass graft surgery. Vasc Health Risk Manag 2006;2:477-484.
12. Shahian DM, Oɻ SM, Sheng S, et al. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation 2012;125:1491-1500.
13. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001;135:1061-1073.
14. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-1729.
15. Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004;43:742-748.
16. Mariscalco G, Klersy C, Zanobini M, et al. Atrial fibrillation after isolated coronary surgery affects late survival. Circulation 2008;118:1612-1618.
17. Núnez J, Sanchis J, Bodí V, et al. Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels. Atherosclerosis 2009;206:251-257.
18. Blum A, Sheiman J, Hasin Y. Leukocytes and acute myocardial infarction. Isr Med Assoc J 2002;4:1060-1065.
19. Reizenstein P. The haematological stress syndrome. Br J Hematol 1979;43:329-334.
20. Dormandy J, Ernst E, Matrai A, et al. Hemorrheological changes following acute myocardial infarction. Am Heart J 1982;104:1364-1367.
21. Craddock PR, Hammerschmidt DE, White JG. Complement (C5-a)-induced granulocyte aggregation in vitro: a possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest 1977;60:260-264.
22. Blum A, Sclarovsky S, Rehavia E, et al. Levels of T lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J 1994;127:1226-1230.
23. Kaufman HS, Kvitash VI. Immunologic abnormalities associated with acute ischemic heart disease (a pilot study). Ann Allergy 1989;63:287-290.
24. Blum A, Massachi R, Miller H. The predictive value of white blood cell count on the success of primary percutaneous intervention of the left anterior descending artery in patients admitted with acute acterior wall myocardial infarction. Eur J Intern Med 2004;15:176-180.
25. Hoffman M, Blum A, Baruch R, et al. Leukocytes and coronary artery disease. Atherosclerosis 2004;172:1-6.
26. Dacey LJ, DeSimone J, Braxton JH, et al. Preoperative white blood cell count and mortality and morbidity after coronary artery bypass grafting. Ann Thorac Surg 2003;76:P760-P764.
27. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-1885.
28. Newall N, Grayson AD, Oo AY, et al. Preoperative white blood cell count is independently associated with higher perioperative cardiac enzyme release and increased 1 year mortality after coronary artery bypass grafting. Ann Thorac Surg 2006;81:583-589.
29. Fontes ML, Amar D, Kulak A, et al. Increased preoperative white blood cell count predicts postoperative atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Vasc Anesth 2009;23:484-487.
30. Brown JR, Landis RC, Chaisson K, et al. Preoperative white blood cell count and risk of 30-day readmission after cardiac surgery. Int J Inflam 2013;2013:781024.
31. Jacob KA, Buijsrogge MP, Frencken JF, et al. White blood cell count and new-onset atrial fibrillation after cardiac surgery. Int J Cardiol 2017;228:971-976.
32. Blum A, Blum N. Coronary artery disease: are men and women created equal? Gend Med 2009;6:410-418.
33. Blankstein R, Ward RP, Arnsdorf M, et al. Female gender is an independent predictor of operative mortality after coronary artery bypass graft surgery: contemporary analysis of 31 Midwestern hospitals. Circulation 2005;112(9 suppl):I323-I327.
34. Vaccarino V, Lin ZQ, Kasl SV, et al. Gender differences in recovery after coronary artery bypass surgery. J Am Coll Cardiol 2003;41:307-314.
35. Gupta S, Agrawal A, Agrawal S, et al. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immun Ageing 2006;3:5.
36. Litjens NH, van Druningen CJ, Betjes MG. Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 2006;118:83-91.
37. Edwards FH, Carey JS, Grover FL, et al. Impact of gender on coronary bypass operative mortality. Ann Thorac Surg 1998;66:125-131.
38. Kardys I, Vliegenthart R, Oudkerk M, et al. The female advantage in cardiovascular disease: do vascular beds contribute equally? Am J Epidemiol 2007;166:403-412.
39. Shaw LJ, Bairey Merz CN, Pepine CJ, et al. Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: I. Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006;47(3 suppl):S4-S20.
40. Shaw LJ, Heller GV, Travin MI, et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol 1999;6:559-569.
41. Shaw LJ, Lewis JF, Hlatky MA, et al. Women’ ischemic syndrome evaluation. Current status and future research directions: report of the National Heart, Lung, and Blood Institute Workshop: October 2-4, 2002. Section 5: gender-related risk factors for ischemic heart disease. Circulation 2004;109:e56-e58.
42. Vaccarino V, Parsons L, Every NR, et al. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 participants. N Engl J Med 1999;341:217-225.
43. Lippincott MF, Carlow A, Desai A, et al. Relation of endothelial function to cardiovascular risk in women with sedentary occupations and without known cardiovascular disease. Am J Cardiol 2008;102:348-352.
44. Gladwin MT, Schechter AN, Ognibene FP, et al. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation 2003;107:271-278.
45. Engin A. Endothelial dysfunction in obesity. Adv Exp Med Biol 2017;960:345-379.